Issued Patents All Time
Showing 1–25 of 30 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12318448 | Use of TLR agonist and anti-CD47 agent to enhance phagocytosis of cancer cells | Irving L. Weissman, Mingye Feng | 2025-06-03 |
| 12274746 | Dosing parameters for CD47 targeting therapies to hematologic malignancies | Ravindra Majeti, Mark P. Chao, Jie Liu, Irving L. Weissman | 2025-04-15 |
| 12258403 | Methods for treating myeloma by achieving therapeutically effective doses of anti-CD47 antibody | Stephen Willingham, Maureen Howard, Jie Liu, Ravindra Majeti, Susan Sweeney Prohaska +2 more | 2025-03-25 |
| 12258399 | Methods for achieving therapeutically effective doses of anti-CD47 agents | Stephen Willingham, Maureen Howard, Jie Liu, Ravindra Majeti, Susan Sweeney Prohaska +2 more | 2025-03-25 |
| 12194093 | Dosing parameters for CD47 targeting therapies to hematologic malignancies | Ravindra Majeti, Mark P. Chao, Jie Liu, Irving L. Weissman | 2025-01-14 |
| 12037402 | Treatment of cancer with dual targeting of CD47 and EGFR | Irving L. Weissman, Stephen Willingham, Doris Po Yi Ho, Piero D. Dalerba, Kelly Marie McKenna | 2024-07-16 |
| 11891450 | Anti-CD47 agent-based treatment of CD20-positive cancer | Mark P. Chao, Chris Hidemi Mizufune Takimoto | 2024-02-06 |
| 11802153 | Anti-CD47 agent-based ovarian cancer therapy | Chris Hidemi Mizufune Takimoto, Mark P. Chao | 2023-10-31 |
| 11766454 | Use of TLR agonist and anti-CD47 agent to enhance phagocytosis of cancer cells | Irving L. Weissman, Mingye Feng | 2023-09-26 |
| 11753480 | Anti-SIRP-alpha antibodies and related methods | Jie Liu | 2023-09-12 |
| 11718670 | Methods for determining and achieving therapeutically effective doses of anti-CD47 agents in treatment of cancer | Irving L. Weissman, Mark P. Chao, Ravindra Majeti, Jie Liu | 2023-08-08 |
| 11718675 | Disrupting FC receptor engagement on macrophages enhances efficacy of anti-SIRPalpha antibody therapy | Jie Liu, Aaron Michael Ring, Irving L. Weissman | 2023-08-08 |
| 11603404 | Methods for treating cancer by achieving therapeutically effective doses of anti-CD47 antibody | Stephen Willingham, Maureen Howard, Jie Liu, Ravindra Majeti, Susan Sweeney Prohaska +2 more | 2023-03-14 |
| 11518806 | Methods for treating cancer by achieving therapeutically effective doses of anti-CD47 antibody | Stephen Willingham, Maureen Howard, Jie Liu, Ravindra Majeti, Susan Sweeney Prohaska +2 more | 2022-12-06 |
| 11472878 | Methods for determining and achieving therapeutically effective doses of anti-CD47 agents in treatment of cancer | Irving L. Weissman, Mark P. Chao, Ravindra Majeti, Jie Liu | 2022-10-18 |
| 11154600 | Use of anti-CD47 agents to enhance immunization | Diane Tseng, Kipp Andrew Weiskopf, Stephen Willingham, Irving L. Weissman | 2021-10-26 |
| 11141480 | Dosing parameters for CD47 targeting therapies to hematologic malignancies | Ravindra Majeti, Mark P. Chao, Jie Liu, Irving L. Weissman | 2021-10-12 |
| 11136391 | Methods for treating cancer by achieving therapeutically effective doses of anti-CD47 antibody | Stephen Willingham, Maureen Howard, Jie Liu, Ravindra Majeti, Susan Sweeney Prohaska +2 more | 2021-10-05 |
| 11130813 | Treatment of cancer with dual targeting of CD47 and EGFR | Irving L. Weissman, Stephen Willingham, Doris Po Yi Ho, Piero D. Dalerba, Kelly Marie McKenna | 2021-09-28 |
| 11104731 | Compositions for achieving therapeutically effective doses of anti-CD47 agents | Stephen Willingham, Maureen Howard, Jie Liu, Ravindra Majeti, Susan Sweeney Prohaska +2 more | 2021-08-31 |
| 10961318 | Anti-SIRP-α antibodies and related methods | Jie Liu | 2021-03-30 |
| 10781256 | Anti SIRP-α antibodies and bi-specific macrophage enhancing antibodies | Kipp Andrew Weiskopf, Aaron Michael Ring, Irving L. Weissman, Nan Guo Ring | 2020-09-22 |
| 10780117 | Macrophages eat cancer cells using their own calreticulin as a guide | Irving L. Weissman, Mingye Feng | 2020-09-22 |
| 10618976 | SIRP-α agonist antibody | Irving L. Weissman, Benson M. George, Nan Guo Ring, Aaron Michael Ring | 2020-04-14 |
| 10611842 | Disrupting FC receptor engagement on macrophages enhances efficacy of anti-SIRPα antibody therapy | Jie Liu, Aaron Michael Ring, Irving L. Weissman | 2020-04-07 |